Upon registration, we invite you to select from the list below three priority topics of your interest for attendance at the Roundiable Discussions. Rate in priority order (1–3) with “1” being preferred choice. We encourage all registrants to select three topics in order to ensure sufficient participation.
Rating
|
Suggested roundtable discussion topics
|
 |
Surveillance methods and inference from surveillance data to inform policy.
|
|
Epidemic modeling to design strategies for epidemic control.
|
|
International surveillance of HIV drug resistance.
|
|
Monitoring of clinical trials involving factorial designs, stopping guidelines, and repeated confidence intervals for curves.
|
|
Signal toxicity in randomized trials for adverse events and long-term follow up of clinical trials using observational methods. Examples include chemokine antagonists, viral tropism, and Phase IV surveillance.
|
|
Statistical and epidemiology issues in the application of causal inference methods: Combining RCT and observational data.
|
|
Predictive modeling: State-of-the-art methods of developing predictive models with clinical utility.
|
|
Strategies for analyses with missing data.
|
|
Multiple testing and multiple endpoints.
|
|
Analytic issues with episodic, repeated exposures.
|
|
Analytic issues using and validating surrogate endpoints.
|
|
Pediatric neurodevelopment, HIV pathogenesis, and markers of HIV progression in children.
|
|
Analytic issues in prevention research: Randomized trials and modeling.
|
|
When to start HAART: Study design and analytic strategies to address the question.
|
| |
|
| |
|
